Rylaze
- Medicine Name: Rylaze
- Generic Name: Asparaginase Erwinia Chrysanthemi (recombinant)¬-rywn
- Dosage Form & Strength: Injection: 10 mg/0.5 mL Solution in a Single-dose Vial
- Manufactured By: Jazz Pharmaceuticals
Medical Uses
Rylaze is an asparagine specific enzyme used as a component of a multi-agent chemotherapeutic regimen to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adult and pediatric patients aged one month or older who are hypersensitive to E. coli-derived asparaginase.
Recommended Dosage: When replacing a long-acting asparaginase product, the recommended dosage is 25 mg/m2 administered intramuscularly every 48 hours.
Warning & Precautions
- Because of the risk of severe allergic reactions (life-threatening anaphylaxis), administer this recombinant injection in a setting with resuscitation equipment and other agents required to treat anaphylaxis. Discontinue therapy in patients with severe hypersensitivity reactions.
- Severe thrombotic events, including sagittal sinus thrombosis and pulmonary embolism, have been observed following therapy with L-asparaginase class products. Rylaze needs to be discontinued for a thrombotic event, and administer apt antithrombotic therapy. Consider resumption of Rylaze treatment only in case the patient had an uncomplicated thrombosis.
- Pancreatitis was reported in patients treated with rylaze injection. Evaluate patients with symptoms compatible with pancreatitis in order to establish a diagnosis. Serum amylase and lipase levels need to be assessed in patients with any signs/symptoms of pancreatitis.
- In patients treated with asparaginase class products, hemorrhage may be associated with increased partial thromboplastin time (PTT), increased prothrombin time (PT), and hypofibrinogenemia. Consider apt replacement therapy in patients with severe or symptomatic coagulopathy.
- Elevated bilirubin or transaminases emerged in patients treated with rylaze 0.5 ml injection. Assess bilirubin and transaminases prior to treatment every 2 to 3 weeks during treatment. In the event of severe liver toxicity, discontinue treatment and provide supportive care.
Documentation & Availability
What documents are required to import RYLAZE to India?
RYLAZE (asparaginase erwinia chrysanthemi) injections can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is RYLAZE available in India?
RYLAZE (asparaginase erwinia chrysanthemi injection) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). S S Healthcare is facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
RYLAZE can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of RYLAZE (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-7575883015 | Toll-Free No: +91-7575883015 or write us at sshealthcare1012@gmail.com for rylaze price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the RYLAZE (Cancer Treatment Medicines) from across the globe, and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Rylaze®?
Asparaginase Erwinia Chrysanthemi (recombinant)¬-rywn is Generic Name for the trade name drug Rylaze®.
What is the Manufacturer Name of Rylaze®?
Rylaze® is manufactured by Jazz Pharmaceuticals.
Is Rylaze® approved by the FDA?
Yes, Rylaze® is approved by the FDA. Date of approval: Jun 30, 2021.
What is Rylaze 10 mg Injection?
Rylaze 10 mg injection, formerly known as JZP458, is an asparagine-specific enzyme approved to treat acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma (LBL) in certain adult and paediatric patients.
What is the dosage and form of Rylaze® supplied?
Rylaze® is supplied as Injection: 10 mg/0.5 mL solution in a single-dose vial for intramuscular administration.
What are the most common side effects due to Rylaze®?
Most common side effects due to Rylaze® include: drug hypersensitivity, pyrexia, abnormal liver test, nausea, musculoskeletal pain, fatigue, infection, headache, febrile neutropenia, stomatitis, decreased appetite, bleeding, and hyperglycemia.
How much does Rylaze cost in India?
The rylaze cost in India is very reasonable. In order to procure this ALL and LBL medication authentically, you can call or WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Rylaze®?
Store Rylaze vials refrigerated at 2-8°C (36-46°F) in the original carton in order to protect from light. Do not shake or freeze.
What are the Highlights of prescribing information for Rylaze®?
Click Here to download full Rylaze prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
